Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China
· Delayed Price · Currency is CNY 15.31
+0.08 (0.53%)
May 23, 2025, 2:45 PM CST
Shinva Medical Instrument Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 641.32 | 691.9 | 676.5 | 500.07 | 556.49 | 234.14 | Upgrade
|
| Depreciation & Amortization | 203.17 | 203.17 | 213.16 | 197.34 | 200.91 | 178.6 | Upgrade
|
| Other Amortization | 49.62 | 49.62 | 45.12 | 43.78 | 52.84 | 16.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.6 | -0.6 | -3.75 | -2.51 | -3.53 | 0.46 | Upgrade
|
| Asset Writedown & Restructuring Costs | 17.33 | 17.33 | 12.87 | 2.03 | 4.51 | 24.97 | Upgrade
|
| Loss (Gain) From Sale of Investments | -70.82 | -70.82 | -93.65 | 7.48 | -172.94 | -51.12 | Upgrade
|
| Provision & Write-off of Bad Debts | 120.59 | 120.59 | 116.98 | 64.33 | 35.09 | 82.15 | Upgrade
|
| Other Operating Activities | 160.36 | 59.5 | 44.84 | 84.52 | 103.56 | -272.9 | Upgrade
|
| Change in Accounts Receivable | -615.58 | -615.58 | 6.82 | -329.1 | -145.01 | 2.32 | Upgrade
|
| Change in Inventory | 190.85 | 190.85 | -540.03 | -726.54 | 18.01 | 256.46 | Upgrade
|
| Change in Accounts Payable | -187.55 | -187.55 | 563.58 | 600.94 | 703.35 | 670.27 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 2.1 | Upgrade
|
| Operating Cash Flow | 501.01 | 450.73 | 1,030 | 388.05 | 1,403 | 1,098 | Upgrade
|
| Operating Cash Flow Growth | -37.38% | -56.24% | 165.46% | -72.33% | 27.72% | 74.05% | Upgrade
|
| Capital Expenditures | -501.67 | -420.88 | -535.77 | -247.58 | -274.36 | -191.33 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.6 | 0.24 | 2.59 | 0.82 | 18.69 | 9.61 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.67 | - | - | Upgrade
|
| Divestitures | - | - | 1.24 | - | 162.48 | 33.97 | Upgrade
|
| Investment in Securities | 32.43 | 43.31 | -4.67 | -40.5 | 205.09 | 11.7 | Upgrade
|
| Other Investing Activities | 49.42 | 58.64 | 16.71 | 5.36 | 10.31 | 2.85 | Upgrade
|
| Investing Cash Flow | -419.22 | -318.71 | -519.9 | -281.22 | 163.89 | -28.39 | Upgrade
|
| Long-Term Debt Issued | - | 1,024 | 1,153 | 1,321 | 1,071 | 2,199 | Upgrade
|
| Long-Term Debt Repaid | - | -1,081 | -1,232 | -1,214 | -2,346 | -2,876 | Upgrade
|
| Net Debt Issued (Repaid) | 27.91 | -56.14 | -78.69 | 106.99 | -1,275 | -676.45 | Upgrade
|
| Issuance of Common Stock | - | - | 1,276 | 62.46 | - | 0.39 | Upgrade
|
| Common Dividends Paid | -290.88 | -329.03 | -103.8 | -96.95 | -128.68 | -183.28 | Upgrade
|
| Other Financing Activities | -22.85 | -21.96 | -27.95 | -44.68 | -4.12 | - | Upgrade
|
| Financing Cash Flow | -291.82 | -407.13 | 1,066 | 27.81 | -1,407 | -859.34 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.84 | 4.03 | 6.95 | 1.4 | 0.24 | 0.01 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.01 | Upgrade
|
| Net Cash Flow | -206.19 | -271.07 | 1,583 | 136.04 | 159.31 | 210.37 | Upgrade
|
| Free Cash Flow | -0.66 | 29.85 | 494.34 | 140.47 | 1,128 | 906.78 | Upgrade
|
| Free Cash Flow Growth | - | -93.96% | 251.91% | -87.55% | 24.42% | 118.43% | Upgrade
|
| Free Cash Flow Margin | -0.01% | 0.30% | 4.94% | 1.51% | 11.90% | 9.91% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.05 | 0.82 | 0.27 | 2.14 | 1.73 | Upgrade
|
| Cash Income Tax Paid | 403.14 | 434.79 | 419.57 | 486.1 | 546.32 | 405 | Upgrade
|
| Levered Free Cash Flow | -278.3 | -359.7 | 311.47 | 115.25 | 948.4 | 994.11 | Upgrade
|
| Unlevered Free Cash Flow | -252.04 | -331.71 | 340.89 | 150.83 | 996.06 | 1,070 | Upgrade
|
| Change in Net Working Capital | 432.07 | 617.24 | -164.81 | 237.33 | -662.1 | -772.55 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.